Next Article in Journal
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial
Previous Article in Journal
Using Measles Outbreaks to Identify Under-Resourced Health Systems in Low- and Middle-Income Countries: A Predictive Model
Previous Article in Special Issue
SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses
 
 
Article

Article Versions Notes

Vaccines 2025, 13(4), 368; https://doi.org/10.3390/vaccines13040368
Action Date Notes Link
article xml file uploaded 30 March 2025 08:02 CEST Original file -
article xml uploaded. 30 March 2025 08:02 CEST Update -
article pdf uploaded. 30 March 2025 08:02 CEST Version of Record https://www.mdpi.com/2076-393X/13/4/368/pdf-vor
article supplementary file uploaded. 30 March 2025 08:02 CEST - https://www.mdpi.com/2076-393X/13/4/368#supplementary
article html file updated 30 March 2025 08:04 CEST Original file -
article xml file uploaded 1 April 2025 11:30 CEST Update -
article xml uploaded. 1 April 2025 11:30 CEST Update https://www.mdpi.com/2076-393X/13/4/368/xml
article pdf uploaded. 1 April 2025 11:30 CEST Updated version of record https://www.mdpi.com/2076-393X/13/4/368/pdf
article html file updated 1 April 2025 11:34 CEST Update https://www.mdpi.com/2076-393X/13/4/368/html
Back to TopTop